RecruitingNCT07221903

The Lateral, Anterior, Medial (LAM) Femoral Cutaneous Block: A Case Series Harborview Medical Center, Seattle, WA


Sponsor

University of Washington

Enrollment

10 participants

Start Date

Oct 22, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Skin donor sites in patients undergoing split-thickness skin grafting surgeries can be very painful postoperatively. This site is most often the anterolateral thigh, the pain at which location can traditionally be covered by a fascia iliaca nerve block, although that comes with the disadvantage of losing motor functions in the femoral nerve distribution. The LAM nerve block, which is relatively new, aims to provide analgesia in the distribution of the lateral and anterior femoral cutaneous nerves. In short, this nerve block would decrease the sensation of the anterolateral thigh area without affecting the motor function of the leg. Investigators aim to study the consistency and coverage size of sensation changes by mapping out the area after the block in each patient.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • years or older
  • Scheduled surgery for STSG w/ donor site coming from thigh
  • Care team requests LAM nerve block
  • Anticipated postop pain in the cutaneous areas of anterior and lateral thigh

Exclusion Criteria9

  • Inability to communicate sensation or motor changes in their body
  • Preexisting sensory or motor deficits in the femoral nerve distribution
  • Contraindication to the medication used or a peripheral nerve block, such as allergy to amide local anesthetics, severe liver dysfunction, injection site infection etc
  • Pregnancy
  • Prisoners
  • Non-English Speaking/reading
  • Surgeries with anticipated or actual duration of 6 hours or longer
  • TBSA 20% or greater
  • Severe distracting injuries/polytrauma (e.g., large or significant bone fractures)

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Harborview Medical Center

Seattle, Washington, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07221903


Related Trials